|
23 Jan 2008 |
Human Genome Sciences Modifies Dosing In Achieve Trials of Albuferon(R)
|
|
23 Jan 2008 |
DIREVO to collaborate with MedImmune on therapeutic protease for the treatment of CNS diseases
|
|
23 Jan 2008 |
Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
|
|
22 Jan 2008 |
Tercica initiates phase II clinical trial with next-generation growth hormone product for the treatment of short stature
|
|
22 Jan 2008 |
Ambrilia Reports Positive Phase III Preliminary Results Showing the Safety and Efficacy of its Prolonged-Release Formulation of Octreotide
|
|
22 Jan 2008 |
Oramed Pharmaceuticals Commences Phase 1B Clinical Trials
|
|
22 Jan 2008 |
Vyteris Announces First Successful Non-Invasive Delivery of Peptide Using Smart Patch Technology
|
|
22 Jan 2008 |
ImaRx and Microbix sign Letter of Intent to manufacture and further develop the FDA-approved clot-dissolving drug, Abbokinase(R)
|
|
22 Jan 2008 |
Protalix Biotherapeutics Extends Research Agreement With Yissum Ltd. Based on Promising Acetylcholinesterase Program Results in Animal Study
|
|
18 Jan 2008 |
Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
|
|
17 Jan 2008 |
FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical
|
|
17 Jan 2008 |
Adherex Announces Phase IIb Expansion of ADH-1 Combination Study in Melanoma
|
|
16 Jan 2008 |
Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
|
|
15 Jan 2008 |
Protox Initiates Phase 2 Prostate Cancer Study
|
|
15 Jan 2008 |
Alfacell Corporation Licenses ONCONASE(R) U.S. Commercial Rights to Strativa Pharmaceuticals
|
|
15 Jan 2008 |
Kamada Announces Successful Completion of Phase I Studies with Aerosolized AAT for the Treatment of Lung Diseases
|
|
15 Jan 2008 |
Molecular Partners AG collaborates with Centocor Research & Development, Inc.
|
|
14 Jan 2008 |
Schering-Plough Reports Top-Line Results of the IDEAL Study
|
|
14 Jan 2008 |
Novo Nordisk refocuses its activities within inhaled insulin and discontinues the development of AERx(R)
|
|
14 Jan 2008 |
ARTES and Minapharm sign long-term strategic development agreement
|
|
14 Jan 2008 |
King Pharmaceuticals Reports FDA Approval Of Revised Labeling Regarding Purity Of THROMBIN-JMI(R)
|
|
14 Jan 2008 |
Three Rivers Pharmaceuticals®, LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
|
|
13 Jan 2008 |
New published data show otoprotective effect of AM-111 in case of inner ear inflammatory responses (acute labyrinthitis)
|
|
11 Jan 2008 |
Jerini Announces Collaboration Agreement with Baxter to Develop Novel Peptide for Use in Therapeutic Protein Purification
|
|
11 Jan 2008 |
LFB Biotechnologies to Collaborate With GTC Biotherapeutics on Coagulation Factor IX Program
|
